Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Giorgio Fedrizzi is active.

Publication


Featured researches published by Giorgio Fedrizzi.


Tetrahedron Letters | 1998

A GENERAL, 1+4 APPROACH TO THE SYNTHESIS OF 3(5)-SUBSTITUTED PYRAZOLES FROM ALDEHYDES

Nicoletta Almirante; Alberto Cerri; Giorgio Fedrizzi; Giuseppe Marazzi; Marco Santagostino

Abstract A new, one-pot preparation of 3(5)-substituted-1H-pyrazole is described that employs Horner-Emmons reaction of aldehydes with dianion of novel phosphonate 1 and proceeds through cyclization of N-sodium salt of α,β-unsaturated tosylhydrazones 2 .


Journal of Medicinal Chemistry | 2008

Novel Analogues of Istaroxime, a Potent Inhibitor of Na+,K+-ATPase: Synthesis and Structure−Activity Relationship†

Mauro Gobbini; Silvia Armaroli; Leonardo Banfi; Alessandra Benicchio; Giulio Carzana; Giorgio Fedrizzi; Patrizia Ferrari; Giuseppe Giacalone; Michele Giubileo; Giuseppe Marazzi; Rosella Micheletti; Barbara Moro; Marco Pozzi; Piero Enrico Scotti; Marco Torri; Alberto Cerri

We report the synthesis and biological properties of novel inhibitors of the Na(+),K(+)-ATPase as positive inotropic compounds. Following our previously described model from which Istaroxime was generated, the 5alpha,14alpha-androstane skeleton was used as a scaffold to study the space around the basic chain of our lead compound. Some compounds demonstrated higher potencies than Istaroxime on the receptor and the (E)-3-[(R)-3-pyrrolidinyl]oxime derivative, 15, was the most potent; as further confirmation of our model, the E isomers of the oxime are more potent than the Z form. The compounds tested in the guinea pig model induced positive inotropic effects, which are correlated to the in vitro inhibitory potency on the Na(+),K(+)-ATPase. The finding that all tested compounds resulted less proarrhythmogenic than digoxin, a currently clinically used positive inotropic agent, suggests that this could be a feature of the 3-aminoalkyloxime derivative class of 5alpha,14alpha-androstane.


Journal of The Chemical Society-perkin Transactions 1 | 1995

New digitalis steroids. Synthesis of 17α-amino 5β,14β-steroids by thermolysis of 17β-azidocarbonyloxymethyl derivatives

Giorgio Fedrizzi; Luigi Bernardi; Giuseppe Marazzi; Piero Melloni; Marco Frigerio

An efficient procedure for the synthesis of otherwise difficult to access 17α-amino derivatives of the digitalis series is described. The key reaction is the stereospecific thermocyclisation of 3β-acetoxy-l7β-azidocarbonyloxymethyl-5β-androstan-14β-ol 3b to (17R)-3β-acetixy-14β-hydroxyspiro[5β-androstane-17,4′-oxazolidin]-2′-one 4.


Journal of Medicinal Chemistry | 1997

17β-(3-Furyl)-5β-androstane-3β,14β,17α-triol (PST 2238). A Very Potent Antihypertensive Agent with a Novel Mechanism of Action

Luisa Quadri; Giuseppe Bianchi; Alberto Cerri; Giorgio Fedrizzi; Patrizia Ferrari; Mauro Gobbini; Piero Melloni; Simona Sputore; Marco Torri


Journal of Medicinal Chemistry | 2001

17α-O-(Aminoalkyl)oxime derivatives of 3β, 14β-dihydroxy-5β-androstane and 3β-hydroxy-14-oxoseco-d-5β-androstane as inhibitors of Na+, K+-ATPase at the digitalis receptor

Mauro Gobbini; Paolo Barassi; Alberto Cerri; Sergio De Munari; Giorgio Fedrizzi; Marco Santagostino; Antonio Schiavone; Marco Torri; Piero Melloni


Journal of Medicinal Chemistry | 2000

17β-O-aminoalkyloximes of 5β-androstane-3β, 14β-diol with digitalis-like activity : Synthesis, cardiotonic activity, structure-activity relationships, and molecular modeling of the Na+, K+-ATPase receptor

Alberto Cerri; Nicoletta Almirante; Paolo Barassi; Alessandra Benicchio; Giorgio Fedrizzi; Patrizia Ferrari; Rosella Micheletti; Luisa Quadri; Enzio Ragg; Roberto Rossi; Marco Santagostino; Antonio Schiavone; Fulvio Serra; Maria Pia Zappavigna; Piero Melloni


Journal of Medicinal Chemistry | 1998

A new approach to the design of novel inhibitors of Na+, K+-ATPase : 17α-substituted seco-D 5β-androstane as Cassaine analogues

Sergio De Munari; Paolo Barassi; Alberto Cerri; Giorgio Fedrizzi; Mauro Gobbini; and Massimo Mabilia; Piero Melloni


Archive | 2007

Azaheterocyclyl derivatives of androstanes and androstenes as medicaments for cardiovascular disorders

Alberto Cerri; Giorgio Fedrizzi; Alessandra Benicchio; Giuseppe Bianchi; Patrizia Ferrari; Mauro Gobbini; Rosamaria Micheletti; Marco Pozzi; Piero Enrico Scotti


Synlett | 1999

β-Tosylhydrazono Phosphonates in Organic Synthesis. An Unambiguous Entry to Polysubstituted Pyrazoles

Nicoletta Almirante; Alessandra Benicchio; Alberto Cerri; Giorgio Fedrizzi; Giuseppe Marazzi; Marco Santagostino


Archive | 2008

Aminooxime derivatives of 2- and/or 4-substituted androstanes and androstenes as medicaments for cardiovascular disorders

Alberto Cerri; Giuseppe Bianchi; Giorgio Fedrizzi; Patrizia Ferrari; Mauro Gobbini; Giuseppe Marazzi; Marco Torri; Walter Cabri

Collaboration


Dive into the Giorgio Fedrizzi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Giuseppe Bianchi

Vita-Salute San Raffaele University

View shared research outputs
Researchain Logo
Decentralizing Knowledge